Jo Patterson CEO
Jo is a managing director and CEO with over 20 years in business and corporate strategy with exposure both in Australia and overseas. She has developed a number of businesses from start-up as well as driving established organisations towards growth and merger trajectories. She has been officially recognised as a successful business executive by winning a number of key business awards and her acumen is evidenced in the success of previous companies in the technology, advertising and health and beauty sectors. Today, Jo has led Bod from its listing on ASX in October 2016, to a growth business expanding globally, inspiring innovation and developing products for the medical and consumer healthcare markets.
Mark Masterson Non-Executive Chairman
Mark Masterson is a leading pharmaceutical executive with over 20 years’ experience throughout multiple geographies. He held a number of senior roles during his time with global healthcare giant, Abbott Laboratories (NYSE: ABT, market capitalisation: US$147.83Bn). At Abbott Laboratories, Mr Masterson held leadership positions across the USA, Europe, Asia and Australia. He was subsequently promoted to Vice President of Commercial Operations in Asia and became a Corporate Officer for the group.
Following his roles with Abbott Laboratories, Mr Masterson became Chief Executive Officer of I-MED, Australia’s largest private diagnostic imaging network. Mr Masterson concluded his four-year tenure at I-MED following the sale of the business to new owners and took up a position as Chairman of Medicines Australia. Medicines Australia is the leading representative body for discovery-driven pharmaceutical companies in Australia.
George Livery Non-Executive Director
George Livery has close to 30 years’ experience in senior roles domestically and internationally. His high-level experience most notably culminated in roles with Swisse Wellness Group, where he began as a Commercial Director and subsequently was promoted to Director of Strategy & Corporate.
During his tenure with Swisse, Mr Livery was responsible for a broad range of initiatives including international business expansion, commercial contracts and agreements, third party and commercial branding opportunities as well as wholesaler and reseller compliance. Mr Livery was instrumental in negotiating the $1.67 billion transaction with Biostime (now H&H Group) and leading the corporate integration and strategy of the two companies post transaction.
Simon O’Loughlin Non-executive Director
Simon O’Loughlin is the founder of O’Loughlins Lawyers, an Adelaide based, specialist commercial law firm. He has extensive experience in the corporate and commercial law fields while practising in Sydney and Adelaide, and also holds accounting qualifications.
Mr O’Loughlin has extensive experience and involvement with companies in the small industrial and resources sectors. He has also been involved in the listing and back-door listing of numerous companies on the ASX, most recently the backdoor listings of The Food Revolution Group Limited (formerly Crest Minerals Limited) and Xref Limited (formerly King Solomon Mines Limited). He is a former Chairman of the Taxation Institute of Australia (SA Division) and Save the Children Fund (SA Division).
Akash Bedi Non-executive Director
Mr Bedi is Chief Strategy & Operations Officer at Health & Happiness Group Limited. He is responsible for progressing strategy and business development opportunities within H&H Group, as well as leading strategic investments for NewH2, the company’s innovation arm. He has considerable experience in global start up investment, as well as the integration of high growth companies and technologies.
Patrice Malard Non-executive Director
Mr Malard boasts a storied career across four decades, culminating in senior roles with international agriculture and food focused companies. Mr Malard holds a PhD in microbial genetics and cell biology from the University of Lille in France and currently acts as Chief Technology Officer of H&H Group. He is also the General Manager of the H&H Group Technical Centre and Chairman of the H&H Group’s BINC Foundation.